Income StatementBalance SheetCash FlowSegments
STERIS logo

STERIS Cash Flow Statement

Operating, investing, and financing cash movements

STERIS generated $1.3B in operating cash flow over the trailing twelve months. After $349.7M in capital expenditures, free cash flow was $917.1M. Free cash flow increased 0.2% year-over-year. Based on the Q4 2025 filing.

Net Cash From Operating (TTM)$1.3BNet Cash From Investing (TTM)-$133.0MNet Cash From Financing (TTM)-$648.4MCapital Expenditures (TTM)$349.7MDepreciation And Amortization Cf (TTM)$485.4MNet Change In Cash (TTM)-$63.8M
Latest FilingQ4 2025
Report Date2026-02-06
Market Cap$20.9B
P/E Ratio29.49
ROE10.43%

Operating

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Other non-cash income (expense)-$3.1M$7.8M—-$14.5M——
Gain on sale of property, plant, and equipment-$500.0K-$300.0K-$2.7M$0.0-$100.0K-$3.2M
Other non-cash income (expense)-$3.1M$7.8M—-$14.5M——
Change in accounts payable——$41.1M$9.8M$13.2M-$28.8M
Change in accounts receivable——$108.1M-$119.2M——
Change in accrued liabilities-$36.8M$30.8M$43.4M-$9.2M-$42.9M—
Change in inventories——-$73.8M$42.5M$18.2M$1.8M
Change in other assets$800.0K$27.0M$31.9M-$18.9M-$6.6M—
Other working capital changes-$3.1M$7.8M—-$14.5M——
Deferred income taxes$0.0-$1.7M-$52.7M$0.0-$100.0K-$100.0K
Depreciation and amortization$115.3M$125.9M$122.3M$119.4M$121.7M$122.0M
Gain (loss) on sale of assets-$500.0K-$300.0K-$2.7M$0.0-$100.0K-$3.2M
Other Non-Cash Income (Expense)-$3.1M$7.8M—-$14.5M——
Other Non-cash Income (Expense)-$3.1M$7.8M—-$14.5M——
Other Non-cash Income (Expense)-$3.1M$7.8M—-$14.5M——
Net cash from operating activities$250.8M$332.8M$260.8M$420.0M$287.8M$298.2M
Net income$151.2M$173.3M$146.1M$178.0M$192.5M$194.3M
Other non-cash income (expense)-$3.1M$7.8M—-$14.5M——
Gain (Loss) on Disposition of Business And Equity Investments, Net——-$10.9M$0.0-$300.0K—
Increase (Decrease) in Prepaid Expense and Other Assets$800.0K$27.0M$31.9M-$18.9M-$6.6M—
Loss on classification as held for sale$0.0$0.0$0.0———
Other Noncash Income (Expense)-$3.1M$7.8M—-$14.5M——
Other Non-cash Income and Expense-$3.1M$7.8M—-$14.5M——
Other Non-Cash Adjustments-$3.1M$7.8M—-$14.5M——
Other Non-Cash Income and Expense-$3.1M$7.8M—-$14.5M——
Stock-based compensation$20.8M$15.3M$9.8M$11.9M$21.2M$15.7M

Investing

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Acquisitions, net of cash acquired$3.8M$36.2M$439.0K$15.0M—$5.1M
Proceeds from sale of other investments$0.0$0.0$0.0———
Capital expenditures$101.9M$89.2M$70.9M$93.6M$86.5M$98.7M
Proceeds from Sale of Other Investments$0.0$0.0$0.0———
Divestiture of businesses, net of cash transferred$300.0K$1.5M—$0.0$0.0$0.0
Proceeds from disposals of property, plant and equipment$0.0$0.0$9.2M$100.0K——
Proceeds from other investments$0.0$0.0$0.0———
Net cash from investing activities———-$108.5M-$88.3M-$98.5M
Proceeds from maturities/sales of investments$0.0$0.0$0.0———
Proceeds from sale of businesses$300.0K$1.5M$3.2M$0.0$0.0$0.0
Proceeds from sale of property, plant and equipment$0.0$0.0$9.2M$100.0K——
Purchases of investments—$0.0$10.8M——$5.0M
Proceeds from Sale of Other Investments$0.0$0.0$0.0———
Proceeds from divestiture of prepaid business$300.0K$1.5M—$0.0$0.0$0.0

Financing

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Proceeds from lines of credit-$91.7M$0.0-$127.3M-$30.5M-$4.3M—
Proceeds from minority shareholders——$32.0K$0.0$0.0$0.0
Contributions from noncontrolling interests——$32.0K$0.0$0.0$0.0
Repayments of debt$0.0$80.0M—$125.0M——
Distributions to noncontrolling interests——$469.0K———
Dividends paid$56.3M$56.2M$56.0M$56.2M$61.9M$61.9M
Payments to Noncontrolling Interests——$469.0K———
Other, net$13.5M$300.0K$6.1M$9.3M$7.6M$15.4M
Repayments of Senior Debt$0.0$80.0M—$125.0M——
Repayments of Term Loans$159.5M$159.5M$159.5M———
Repayments of Secured Debt———$0.0$0.0$0.0
Net proceeds from sales of subsidiary shares——$32.0K$0.0$0.0$0.0
Payment of Deferred Purchase Consideration$13.5M$300.0K$6.1M$9.3M$7.6M$15.4M
Noncontrolling interest transactions and other$13.5M$300.0K$6.1M$9.3M$7.6M$15.4M
Proceeds from Minority Shareholders——$32.0K$0.0$0.0$0.0
Proceeds from Sale of Noncontrolling Interests——$32.0K$0.0$0.0$0.0
Net cash from financing activities-$181.0M-$214.4M-$178.1M-$213.1M-$159.2M-$98.0M
Other financing activities$13.5M$300.0K$6.1M$9.3M$7.6M$15.4M
Payment of debt issuance costs——$16.0K———
Noncontrolling Interests Activity and Other$13.5M$300.0K$6.1M$9.3M$7.6M$15.4M
Proceeds from Minority Shareholders——$32.0K$0.0$0.0$0.0
Repurchases of common stock$46.4M$100.5M$221.0K$10.6M$100.5M$50.1M
Proceeds from Minority Shareholders——$32.0K$0.0$0.0$0.0
Payments of consent fees related to long-term debt——$16.0K———

Free Cash Flow

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Free cash flow$148.9M$243.6M$189.9M$326.4M$201.3M$199.5M

Other

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Effect of exchange rate changes on cash$9.4M-$11.5M$3.6M$9.6M—$2.9M
Net increase (decrease) in cash-$26.1M-$17.0M—$108.0M$39.5M$104.5M
Payments Of Merger Related Costs Financing Activities$100.0K$100.0K$55.0K$100.0K$100.0K$100.0K